Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing

Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing

Background: Therapeutic phlebotomy, known as scheduled bloodletting, has been the main method for managing erythrocytosis symptoms and thrombocytosis-associated complications in various blood disorders. One of the major indications for phlebotomy is polycythemia vera (PV). The main goal of current t...

Full description

Bibliographic Details
Main Authors: Wei-Zhi Lin, Chi-Hsiang Chung, Chia-Yang Shaiu, Bing-Heng Yang, Wu-Chien Chien
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
hydralazine
valproate
therapeutic phlebotomy
cohort study
population-based study
national health insurance database
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.850045/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.850045/full

Similar Items